Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene for unexplained male infertility with low sperm count
ACTRN12623000329662Phase 3Recruiting
- Sponsor
- Hudson Institute of Medical Research
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in male infertility and oligospermia comparing Clomiphene + Menevit with Placebo + Menevit (2 arms). Primary endpoint: Total sperm count. Started Nov 2024; status: recruiting.
02
Drugs
clomiphene
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on ACTRN12623000329662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000329662.